Establishment of the active catalytic domain of human PDGFRβ tyrosine kinase-based ELISA assay for inhibitor screening-Reference-Cited by-同舟云学术

Establishment of the active catalytic domain of human PDGFRβ tyrosine kinase-based ELISA assay for inhibitor screening

Published:2007-10 Issue:10 Volume:1770 Page:1490-1497
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Zhang Xiu-Hua,Guo Xiao-Ning,Zhong Li,Luo Xiao-Min,Jiang Hua-Liang,Lin Li-Ping,Ding Jian

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference27 articles.

1. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma;Coltrera;Cancer Res.,1995

2. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium;Dabrow;Gynecol. Oncol.,1998

3. Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors;Hofer;Neoplasia,2004

4. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas;Lafuente;J. Mol. Neurosci.,1999

5. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer;Lindmark;Lab. Invest.,1993

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains;PLoS ONE;2014-07-16

2. Shp-2 regulates the TrkB receptor activity in the retinal ganglion cells under glaucomatous stress;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2012-11

3. Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress;Journal of Molecular Neuroscience;2012-10-07

4. BB, a new EGFR inhibitor, exhibits prominent anti-angiogenesis and antitumor activities;Cancer Biology & Therapy;2009-09

5. The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo;PLoS ONE;2008-11-20